Azenta, Inc., a leading provider of life sciences solutions worldwide, announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems business to Thelema S.À R.L., for a purchase price of USD 63 million. The transaction is expected to close on or before March 31, 2026.

"The agreement to sell B Medical Systems marks a major step forward in simplifying the portfolio to prioritize our core capabilities with the highest strategic impact," said John Marotta, president and CEO. "The proceeds from this sale will be deployed to strengthen the company and drive long-term profitable value creation for our shareholders."

B Medical Systems is a global manufacturer and distributor of medical refrigeration devices based in Luxembourg.

William Blair served as exclusive financial advisor and Taylor Wessing served as legal counsel to Azenta for this transaction.

Azenta, Inc. is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.